BIO · Company research
Bio-Rad Laboratories, Inc.Class A (BIO): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 368.83 | $10,230,612,000 | 9713612000 | 17.494582881906826 | — | 0.9365219368433613 | 15.7152258064516129 | 1.4260879019780036 | 156.9112269938650292 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.